compare glp 1 agonists Table from Glucagon-Like Peptide-1 (GLP-1) Receptor Drug Class Review Comparison of GLP-1 receptor agonists

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

Novo Nordisk noted the comparison used a low dose of semaglutide rather than the higher-dose oral Wegovy approved for weight loss, but the pattern holds: Foundayo delivers meaningful results without rigid protocol

In mice, NNC00902764 demonstrates superior body weight reduction relative to pharmacokinetically-matched GLP-1R monoagonism and this difference was lost with ablation of CNS-GIPR expression 54

Some researchers are exploring combining tesamorelin with retatrutide to add growth hormone releasing hormone (GHRH) effects on top of the triple agonism

Egecioglu E, Steensland P, Fredriksson I, Feltmann K, Engel JA, Jerlhag E

Future research also could explore the effects of individual GLP-1 agents rather than the drug class as a whole